Jarabek A M, Menache M G, Overton J H, Dourson M L, Miller F J
U.S. Environmental Protection Agency, Office of Health and Environmental Assessment, Research Triangle Park, North Carolina 27711.
Toxicol Ind Health. 1990 Oct;6(5):279-301.
The U.S. Environmental Protection Agency (U.S. EPA) has advocated the establishment of general and scientific guidelines for the evaluation of toxicological data and their use in deriving benchmark values to protect exposed populations from adverse health effects. The Agency's reference dose (RfD) methodology for deriving benchmark values for noncancer toxicity originally addressed risk assessment of oral exposures. This paper presents a brief background on the development of the inhalation reference dose (RfDi) methodology, including concepts and issues related to addressing the dynamics of the respiratory system as the portal of entry. Different dosimetric adjustments are described that were incorporated into the methodology to account for the nature of the inhaled agent (particle or gas) and the site of the observed toxic effects (respiratory or extrarespiratory). Impacts of these adjustments on the extrapolation of toxicity data of inhaled agents for human health risk assessment and future research directions are also discussed.
美国环境保护局(U.S. EPA)倡导制定用于评估毒理学数据及其在推导基准值以保护受暴露人群免受不良健康影响方面应用的通用科学指南。该机构用于推导非癌症毒性基准值的参考剂量(RfD)方法最初针对的是口服暴露的风险评估。本文简要介绍了吸入参考剂量(RfDi)方法的发展背景,包括与将呼吸系统作为进入途径的动态过程相关的概念和问题。描述了为考虑吸入剂的性质(颗粒或气体)以及观察到的毒性效应部位(呼吸或呼吸外)而纳入该方法的不同剂量学调整。还讨论了这些调整对吸入剂毒性数据外推以进行人类健康风险评估的影响以及未来的研究方向。